SOTIO to Present at the LifeSci Partners Summer Symposium
PRAGUE, Czech Republic, July 30, 2020 (GLOBE NEWSWIRE) -- SOTIO, a clinical stage immuno-oncology company owned by PPF Group, today announced that Radek Špíšek, chief executive officer of SOTIO, will be presenting a corporate overview at the Private Healthcare Company Virtual Summer Symposium, hosted by LifeSci Partners on August 4 and 5, 2020. Please click the following link to register: https://lifesci.events/SummerSymposium
| Presentation Details: | ||
| Date: | August 5, 2020 | |
| Time: | 10:00 a.m. EDT | |
| Company contact: | Media contact: | |
| Richard Kapsa | Kirsten Frazer, Ph.D. | |
| Head of Communication | LifeSci Communications | |
| T: (+420) 224 174 448 | T: +1 646-863-0222 | |
| M: (+420) 603 280 971 | kfrazer@lifescicomms.com | |
| kapsa@sotio.com |
About SOTIO
SOTIO is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO’s robust clinical pipeline includes a differentiated superagonist of the attractive immuno-oncology target IL-15, a platform to streamline personalized active immune cell therapies and a new generation of potent and stable antibody-drug conjugates (ADCs). SOTIO is a member of the PPF Group. For more information, please visit the company’s website at www.sotio.com.
SOTIO is a registered trademark of SOTIO a.s. in selected countries.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
